RSI low/high Values: [ 25 - 70 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LTRN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lantern Pharma Inc. stock price ended at $4.29 on Wednesday, after losing 2.50%.
(Updated on Jul 03, 2024)

Sell candidate since Jun 05, 2024 Loss -29.79% PDF

The Lantern Pharma Inc. stock price fell by -2.50% on the last day (Wednesday, 3rd Jul 2024) from $4.40 to $4.29. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.53% from a day low at $4.25 to a day high of $4.57. The price has fallen in 6 of the last 10 days and is down by -8.53% for this period. Volume has increased on the last day by 5 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 26 thousand shares were bought and sold for approximately $109.48 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.23% during the next 3 months and, with a 90% probability hold a price between $2.42 and $3.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LTRN Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 24, 2024, and so far it has risen 9.72%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lantern Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $4.39 and $5.45. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Lantern Pharma Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Lantern Pharma Inc. stock

Lantern Pharma Inc. finds support from accumulated volume at $4.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.320 between high and low, or 7.53%. For the last week, the stock has had daily average volatility of 8.38%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LTRN) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Lantern Pharma Inc. to open at $4.37, and during the day (based on 14 day Average True Range), to move between $3.87 and $4.71, which gives a possible trading interval of +/-$0.417 (+/-9.71%) up or down from last closing price. If Lantern Pharma Inc. takes out the full calculated possible swing range there will be an estimated 19.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.15 (3.26%) than the resistance at $4.91 (14.45%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lantern Pharma Inc. stock A Buy?

Lantern Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.148 Sell Candidate Unchanged

Predicted Opening Price for Lantern Pharma Inc. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$4.37 ( 1.86%) $4.29

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LTRN

Fibonacci Support & Resistance Levels

Level Price
R3 4.69 9.32%
R2 4.57 6.47%
R1 4.49 4.71%
Price 4.29
S1 4.25 -0.98%
S2 4.17 -2.74%
S3 4.05 -5.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.34 24.48%
R2 4.93 14.92%
R1 4.91 14.45%
Price 4.29
S1 4.15 -3.26%
S2 4.01 -6.53%
S3 3.91 -8.86%

FAQ

What is the symbol for Lantern Pharma Inc. Stock and on which exchange is it traded?
The symbol for Lantern Pharma Inc. is LTRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lantern Pharma Inc. Stock?
Lantern Pharma Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lantern Pharma Inc. Stock?
Lantern Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lantern Pharma Inc. Stock.

What's the current price of Lantern Pharma Inc. Stock?
As of the end of day on the Jul 03, 2024, the price of an Lantern Pharma Inc. (LTRN) share was $4.29.

What is the 52-week high and low for Lantern Pharma Inc. Stock?
The 52-week high for Lantern Pharma Inc. Stock is $11.98 and the 52-week low is $2.38.

What is the market capitalization of Lantern Pharma Inc. Stock?
As of the Jul 03, 2024, the market capitalization of Lantern Pharma Inc. is 46.155M.

When is the next earnings date for Lantern Pharma Inc.?
The upcoming earnings date for Lantern Pharma Inc. is Aug 14, 2024.
Click to get the best stock tips daily for free!

About Lantern Pharma Inc.

Lantern Pharma. Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In ... LTRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT